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Functionalized computed tomography (CT) in combination with labelled cells is
virtually non-existent due to the limited sensitivity of X-ray-absorption-based
imaging, but would be highly desirable to realise cell tracking studies in entire
organisms. In this study we applied in-line free propagation X-ray phase-
contrast CT (XPCT) in an allergic asthma mouse model to assess structural
changes as well as the biodistribution of barium-labelled macrophages in lung
tissue. Alveolar macrophages that were barium-sulfate-loaded and fluorescent-
labelled were instilled intratracheally into asthmatic and control mice. Mice
were sacrificed after 24 h, lungs were kept in situ, inflated with air and scanned
utilizing XPCT at the SYRMEP beamline (Elettra Synchrotron Light Source,
Italy). Single-distance phase retrieval was used to generate data sets with ten
times greater contrast-to-noise ratio than absorption-based CT (in our setup),
thus allowing to depict and quantify structural hallmarks of asthmatic lungs such
as reduced air volume, obstruction of airways and increased soft-tissue content.
Furthermore, we found a higher concentration as well as a specific accumulation
of the barium-labelled macrophages in asthmatic lung tissue. It is believe that
XPCTwill be beneficial in preclinical asthma research for both the assessment of
therapeutic response as well as the analysis of the role of the recruitment of
macrophages to inflammatory sites.
Keywords: phase-contrast CT; single-distance phase retrieval; functional CT imaging.
1. Introduction
Lung imaging, especially of the mouse, remains extremely
challenging due to the small size and high porosity nature of
the organ, which creates various problems like scattering for
X-ray and optical imaging techniques, susceptibility artefacts
in magnetic resonance imaging (MRI) and shadowing of
medical ultrasound waves at the rib cage. Together with
preclinical airway disease models, novel imaging technologies
are becoming increasingly important for monitoring disease
progression and the efficacy of treatment within the lung.
Recent studies have either focused on functional aspects,
utilizing near-infrared fluorescence (NIRF) imaging (Napp et
al., 2010; Markus et al., 2014) or on the depiction of morpho-
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logical alterations, such as airway wall thickening using ex vivo
micro-CT (Cortez-Retamozo et al., 2008; Sera et al., 2007). For
tracking of ex vivo labelled immune cells in vivo a wide range
of imaging modalities, for example MRI (Ahrens & Bulte,
2013) and optical imaging (Bousso & Moreau, 2012), have
been reported in recent years. Radionuclide labelling of cells is
the oldest technique for tracking immune cells, especially in
whole body distribution studies in humans (Thakur, 1977).
The application of CT in combination with novel contrast
agents for cell tracking has just begun to be explored and is
hampered by the poor sensitivity of CT combined with the low
toleration of high concentrations of contrast media loaded
into cells (Cormode et al., 2014). In order to visualize the
biodistribution of labelled cells following injection, as well as
to assess morphological alterations in great detail during
inflammation and airway remodelling within the lung, the
combination of high spatial resolution with increased sensi-
tivity is highly desirable. An imaging technique that meets
these requirements is the here-used in-line free-propagation
X-ray phase contrast CT (XPCT).
Since the very first application of X-rays for medical
purposes by Konrad Roentgen in 1895, the imaging principle
for detecting tissue-dependent variations by X-ray absorption
has remained unchanged. Especially in applications related to
visualization of soft-tissue as in mammography or in lung
imaging, these differences in X-ray absorption are very weak,
resulting in poor contrast. This contrast could be raised by
lowering the X-ray photon energy; however, this would also
increase the radiation dose deposition in the samples. Addi-
tionally, an energy level high enough to achieve sufficient
penetration of the sample needs to be maintained. Due to
these factors the absorption contrast in radiographs is limited,
especially in clinical practice. In addition to absorption, a
phase shift of the incident X-ray wavefront occurs within the
sample. Despite being about 100 times stronger in low-density
materials (Takeda et al., 1995), this effect has basically not
been exploited in clinical routine to date, due to the fact that at
least partial coherent X-rays are required, which can only be
generated with micro-focus X-ray tubes, or with higher
intensities, at synchrotron light sources (Nugent, 2010). This
limitation notwithstanding, X-ray phase-contrast imaging has
great potential, as it combines strong edge enhancement in
radiographs with the fact that the advantage of phase contrast
over conventional absorption contrast improves with
increasing photon energy. Therefore, medical phase-contrast
X-ray imaging could potentially be performed at higher
energies than in the actual absorption-based regime, which
would reduce the dose deposition within the patient, espe-
cially in soft-tissue applications like mammography. There are
already some clinical mammography systems on the market
demonstrating a gain in image contrast due to phase effects
(Tanaka et al., 2005). Besides the here-used in-line free-
propagation XPCT, there are other phase-sensitive techniques
such as grating interferometry (Pfeiffer et al., 2006). Grating
interferometry would allow phase-contrast imaging even when
conventional X-ray tubes are used. Notwithstanding that the
clinical application of this technique is at the moment
hampered by technical problems such as the magnitude of the
applied radiation dose, grating interferometry also showed
very promising results in lung imaging as demonstrated by
Schleede et al. (2012).
Since absorption-based CT imaging in its nature shows low
sensitivity, functional imaging approaches similar to those
used in SPECT, PET or optical imaging (Nahrendorf et al.,
2008) are virtually nonexistent. The potential of phase-sensi-
tive techniques for lung imaging has been explored since the
late 1990s at some synchrotron beamlines (Yagi et al., 1999;
Kitchen et al., 2004; Lewis et al., 2005; Hooper et al., 2007,
2009). However, the increased sensitivity of XPCT in less
dense materials might be well suited to realise CT functional
imaging addressing both soft-tissue alterations and the
distribution of heavy-ion-based contrast agents such as barium
sulfate. Contrary to classical absorption-based CT, in XPCT
edge enhancement caused by phase effects at tissue interfaces
is superimposed on the contrast caused by tissue-specific
differences in X-ray absorption. These interactions of X-rays
with matter are described by the complex refractive index
~n = 1   + i, where  determines the phase shift and  the
absorption. In order to analyse the phase shift separately, the 
part of the signal needs to be decoupled by a phase-retrieval
(PhR) algorithm. It has already been demonstrated that the
application of PhR is highly beneficial in the analysis of
biological samples (Keyrila¨inen et al., 2010; Zhang et al., 2011;
Yong et al., 2009; Gureyev et al., 2013) showing an up to 200-
fold improvement in the contrast-to-noise ratio (Beltran et al.,
2011). A large variety of PhR algorithms have been reported
so far, that can be loosely divided into multi- and single-
distance techniques (Nugent, 2007).
Commonly used multi-distance PhR approaches are either
based on the fact that the absorption part of the detected
radiograph is constant whereas the impact of the phase effects
varies with different sample-to-detector distances, or require
a priori knowledge of the refractive indexes within the sample
(Cloetens et al., 1999a; Beltran et al., 2010). Imaging with
several sample-to-detector distances is disadvantageous
because it crucially depends on a perfect alignment of the
different scans and it is affected by variations in the X-ray
beam, which often occur at synchrotron light sources. In
contrast to that, single-distance PhR algorithms minimize the
scanning time and are therefore especially suitable for the
analysis of unfixed biological samples such as in situ mouse
lungs imaged in this study, but they can strictly only be applied
on objects expressing a constant -to- ratio (Paganin et al.,
2002). However, the applicability of this type of algorithm for
soft-tissue samples was shown by Wu et al. (2005). Moreover,
single-distance PhR followed by standard filtered back-
projection reconstruction (FBP) was applied to generate
three-dimensional (3D) data sets of mouse lungs predomi-
nately presenting the distribution of the  part of the refractive
index (Mohammadi et al., 2014).
The aim of this study was to develop a functional XPCT
imaging approach (fXPCT) by exploiting the capability of
alveolar macrophages (M) to migrate to inflammatory sites
within the lung using an ovalbumin induced experimental
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allergic airways disease model (Markus et al., 2014). In order
to visualize the biodistribution of cells following intratracheal
application, M of the immortalized alveolar macrophage cell
line MH-S (Mbawuike & Herscowitz, 1989) were ex vivo
labelled by adding a contrast agent suitable for X-ray-based
imaging directly to the cell culture media. A barium sulfate
suspension was used, that is commonly applied in the clinic to
mark the gastrointestinal tract in CT (Golder et al., 1991).
Thereby, macrophages were intracellularly labelled and used
as a specific probe instead of an in situ labelling approach by
systemic administration of X-ray contrast agents. M can
engulf large particles by phagocytosis and can therefore easily
be loaded with contrast agents and drugs in vitro (Trivedi et al.,
2006), converting them into potential carriers for both diag-
nostic and therapeutic agents. Since they migrate to inflam-
matory sites they have already been exploited for delivery of
various anti-inflammatory compounds (Bang et al., 2011;
Moreira & Hogaboam, 2011; Yang et al., 2012). Moreover, M
were recently identified as one of the main effector cells in
asthma (Bang et al., 2011; Moreira & Hogaboam, 2011; Yang et
al., 2012). Mizue et al. (2005) showed that, in the absence of
the macrophage migration inhibitory factor (MIF), asthma
could not be induced in MIF-deficient mice, and Chen et al.
(2010a) demonstrated in an asthma mouse model that airway
remodelling was successfully inhibited by a MIF antagonist.
With the unique capabilities of XPCT in combination with
phase retrieval and the use of M loaded with barium sulfate
particles, we were able to simultaneously depict and quantify
structural features and to illustrate in 3D the different accu-
mulation sites of labelled M within asthmatic and control
lungs. We believe that, by providing new quantitative func-
tional and anatomical parameters and by using barium-
labelled immune cells in cell trafficking studies, this novel
fXPCTapproach may help to preclinically investigate complex
and multi-factorial processes of inflammatory diseases.
2. Material and methods
2.1. Preparation and labelling of macrophages
The immortalized mouse alveolar M cell line MH-S
(purchased from American Type Culture Collection, ATCC,
USA) was maintained in RPMI medium, supplemented with
10% FCS and 0.05 mM 2-mercaptoethanol (Mbawuike &
Herscowitz, 1989) in a humidified atmosphere at 5% CO2 and
310 K. For CT imaging, cells were loaded with a barium sulfate
suspension, the clinically used contrast agent Micropaque CT
(Guerbet, France) by co-incubating 1 106 cells ml1 for 24 h
with 3.5 ml Micropaque CT/ml cell media (175 mg barium
sulfate/ml media), followed by two washing steps with phos-
phate buffer (PBS). Subsequently, for stable fluorescent
labelling of the cell membrane, the M were incubated for
30 min with 5 ml ml1 of the lipophilic dialkylcarbocyanine
dye Vibrant DiD (DiD; Molecular Probes, Eugene, OR, USA;
excitation maximum: 644 nm; emission maximum: 665 nm),
followed by two washing steps with PBS. To test the loading
efficacy of barium sulfate particles into M, a vial containing
1  105 barium sulfate M resuspended in 100 ml PBS was
scanned with a normal bench-top microCT (eXplore locus SP,
GE HealthCare, USA) (Verdelis et al., 2011). The morphology
of the barium-labelled M was assessed by light microscopy
and the effects of the uptake of barium sulfate particles on the
metabolic activity of M were investigated with a water-
soluble tetrazolium (WST-1) cell proliferation assay (Madison,
WI, USA) (Mosmann, 1983).
2.2. Mouse model of allergic asthma
Female BALB/c mice (4–6 weeks old) were purchased from
Harlan Laboratories and maintained with ‘ad libitum’ food
and water. For generation of the experimental allergic airways
disease model, mice were sensitized intraperitoneally (i.p.) at
day 0 and 21 with 10 mg ovalbumin (OVA), dissolved in 200 ml
PBS. At day 28 and 29, mice were treated intranasally (i.n.)
with a solution of 100 mg OVA/50 ml PBS to induce an acute
allergic reaction (Biffi et al., 2013). Healthy age and gender-
matched BALB/c mice, immunized and challenged with PBS
only, were used as controls. To verify the success of OVA
immunization, blood samples were taken 72 h after the last
challenge from the facial vein of the living mice and levels of
OVA-specific immunoglobulin within the sera were analysed
as previously described (Biffi et al., 2013).
Animal in vivo procedures were performed at the CBM
Animal Facility, Trieste, Italy, in compliance with the guide-
lines of the European (86/609/EEC), the Italian (DL116/92)
and at the University Medical Center Go¨ttingen, Germany, in
accordance with the German ethical laws (33.9-42502-04-10/
0134) and were approved by the Italian Ministry of Health as
well as by the animal ethics administration of Lower Saxony,
Germany.
2.3. Application of macrophages and experimental setup
Previous differential cell counts from bronchoalveolar
lavages (BAL) and in vivo fluorescence measurement
experiments showed that OVA-induced asthmatic mice
display the strongest signs of inflammation between 48 h and
72 h after the last antigen challenge (Biffi et al., 2013). We
therefore instilled 6  106 barium- and DiD-labelled M
resuspended in 30 ml PBS intratracheally (i.t.) 72 h after the
last OVA challenge into the lungs of asthmatic and control
mice under xylazine-tiletamine-zolazepam anaesthesia.
2.4. In vivo optical imaging
Optical imaging was performed by two-dimensional fluor-
escence reflectance imaging (FRI) using the Optix MX2
system (ART; Montreal, Canada) as previously described
(Markus et al., 2014). For in vivo scans, mice were anaes-
thetized by inhalation with isoflurane (2% isoflurane in 2 l
oxygen per min). Before imaging, mice were shaved and
chemically depilated over thorax and abdomen to decrease
scattering from the fur. Mice were scanned before, directly
after and 24 h after M instillation. All data were acquired
using a 670 nm excitation laser diode in combination with a
700 Lp emission filter and a 1.0 mm raster. The fluorescence
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intensity was analysed using the OptiView-2-02-00 software
(ART). The average intensity of the lung area was measured
and its relative increase compared with the pre-scan was
computed.
2.5. Preparation of biological samples for ex vivo CT analysis
Mice were sacrificed 24 h after instillation of barium-
sulfate-loaded and fluorescent-labelled M (Fig. 1) using a
xylazine-tiletamine-zolazepam overdose. In order to ensure
comparability between different samples, all lungs were
inflated in situ with air, under a constant pressure of 30 cm
water column (2.94 kPa) through a series of smaller tubes,
which ended in a PE50 polyethylene cannula fixed inside the
trachea with a cotton thread. Tracheas were tied up and all
samples were kept at room temperature for 2 h, in order to
avoid any alterations caused by rigor mortis. To avoid air
leakage, alterations and movements during the X-ray exam-
ination, samples were then embedded in a 1% agarose gel
inside 30 ml tubes (Fisher Scientific, USA) and kept for 30 min
at 277 K. Samples were moved to the synchrotron beamline
30 min before scanning to allow for temperature adaptation.
Four lung samples were prepared for fXPCT analysis: one
mouse with OVA-induced asthma and two healthy controls, all
injected with M (AA, CN1 and CN2), as well as one healthy
mouse without application of M which served as a negative
control (Blk).
2.6. Synchrotron-radiation-based fXPCT and phase retrieval
All data sets were acquired at the SYRMEP beamline at the
synchrotron light source Elettra (Trieste, Italy) (Brun et al.,
2010; Dreossi et al., 2008), which is especially designed for
medical applications and analysis of biological samples. The
beamline was operated at 22 keV at a sample-to-detector
distance of 30 cm. The central area of the lung of each sample
was scanned by performing two overlapping 360 scans with
1800 projections each and a 2  2 binning of the detector
elements, thus resulting in a spatial resolution of 9 mm. In
order to decouple phase and absorption information in the
acquired projection images, we applied a single-distance in-
line phase-retrieval algorithm based on the Born equation
implemented by Chen et al., which only requires one data set,
obtained at a single sample-to-detector distance (Mohammadi
et al., 2014; Chen et al., 2010b, 2012; Taylor, 1981). In order to
apply this class of algorithms, a priori knowledge of the -to-
ratio within the sample is needed. Within this study we used
a -to- ratio of 1950 for standardized lung tissue with a
hydrogen, carbon and oxygen ratio: H10 C0.83 O5 (Interna-
tional Commission on Radiological Protection) (Mohammadi
et al., 2014).
2.7. Quantification of morphological alterations within the
lung and distribution of barium-loaded macrophages
For a quantitative comparison of the lung samples it is
crucial to identify parameters that characterize the alterations
in the lung structure without being affected by local in-
homogeneities in the manifestation of the asthmatic reaction
within the lung. To this end we applied an analysis scheme that
was adapted from strategies used for the characterization of
trabecular bone structure and other porous materials. Briefly,
the data sets were reoriented and resampled to ensure that the
analysis is independent of the orientation of the lungs during
the scan. Due to the high contrast-to-noise ratio in the phase-
retrieved reconstructed data sets, non-overlapping greyscale
ranges were assigned to air, lung soft-tissue, bone of the rib
cage and to barium used as label for the i.t. instilled M.
These image segments were then further analysed and quan-
tified in terms of air, soft-tissue and barium content as well as
narrowing of the airways.
2.8. Histology
Lung samples for histology were obtained from a further set
of OVA-induced asthmatic and control mice following the
schedule and conditions as described in Fig. 1 (in order to be
comparable with the fXPCT analysis). The excised lungs were
fixed in 10% buffered formalin and embedded in paraffin, and
3 mm-thick paraffin lung sections containing main stem
bronchi were obtained. A periodic acid-Schiff (PAS) staining
was performed to assess bronchial wall thickness and mucus
production (Fullmer, 1960). Sections were deparaffinised,
rehydrated and stained with periodic acid for 5 min, followed
by Schiffs reagent (Merck, Darmstadt, Germany) for 15 min
and hematoxylin for 2 min. Slices were washed for 3 min
between each of the staining steps. The samples were dehy-
drated using an ascending alcohol series and Xylol and finally
mounted with DePex (Serva, Heidelberg, Germany). An
Axioskop 2 (Carl Zeiss Microscopy GmbH, Jena, Germany)
microscope in combination with a Leica DC 100 camera
(Leica, Switzerland) was used for analysis of the stained
sections.
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Figure 1
Experimental setup. An OVA allergen-induced experimental allergic
airways disease model was used, consisting of two immunization steps
(i.p. injection of 10 mg OVA) on days 0 and 21 and two challenging steps
(i.n. application of 100 mg OVA) on days 28 and 29. Prior to their
instillation, M were labelled with Micropaque and DiD for 24 and 4 h,
respectively. On day 32, 6  106 barium- and DiD-labelled M were
instilled i.t. into asthmatic and control mice. Mice were euthanized on day
33 and prepared for fXPCT analysis.
2.9. Fluorescence microscopy
In order to verify the location of the injected DiD and
barium-labelled M, fluorescence microscopy of lung tissue
sections of asthmatic and control mice was performed,
utilizing an Axiovert 200M inverted microscope (Carl Zeiss
Microscopy) equipped with a xenon lamp and a high-sensi-
tivity ORCA-AG digital camera (Hamamatsu, Japan), capable
of NIRF detection. For this purpose, lungs of asthmatic mice
(n = 2) and a control mouse, explanted 24 h after M i.t.
instillation, were filled with optimal-cutting-temperature
(OCT) embedding material (Tissue-Tek; Sakura Finetek,
Torrance, CA, USA) and were cryofrozen. Lung cryosections
(5 mm) were obtained, fixed with acetone (10 min at 253 K)
and washed with tris(hydroxymethyl)-aminomethane (Tris)
buffer (pH 7.5). Immunostaining was performed as follows.
Autofluorescence was blocked with 0.1M glycin [for 10 min at
room temperature (RT)], endogenous biotin and avidin were
blocked with Avidin Biotin Blocking Solution and unspecific
binding sites for 20 min at RT with SEA BLOCK blocking
buffer (both Thermo Scientific) following the manufacturer’s
protocol. Slices were then incubated overnight at 277 K
with rat monoclonal anti-CD68 antibody (FA-11; Abcam,
Cambridge, UK; 3.33 mg ml1) diluted in Antibody Diluent
with Background Reducing Components (DAKO, Glostrup,
Denmark), followed by two incubation steps of 1 h at RTwith
biotinylated goat–anti-rat antibody (BioLegend, San Diego,
CA, USA; 1:200), and with Streptavidin-AlexaFluor 555
(Molecular Probes, Life Technologies, Carlsbad, CA, USA;
1:400). Finally, slices were mounted with Mowiol (Cali-
biochem, Merck, Darmstadt, Germany) supplemented with
40,6-diamidino-2-phenylindole (DAPI) for staining of the
nuclei and left overnight at 277 K. Two washing steps with Tris
buffer were performed between each step. DiD fluorescence
was acquired using a band-pass (BP) 640  15 nm excitation
filter, a 660 nm dichroic mirror and a BP 690 25 nm emission
filter. The AlexaFluor 555 signals were recorded using a BP
546  6 nm excitation filter, a 580 nm dichroic mirror and a
590 nm long pass emission filter. DAPI fluorescence was
acquired using a BP 365  12.5 nm excitation filter, a 395 nm
dichroic mirror and a BP 445  25 nm emission filter. In the
produced images the DAPI channel was set to blue, Alexa-
Fluor 555 to green and DiD to red. Image generation and
processing were performed using the software AxioVi-
sion Rel.4.6 (Carl Zeiss Microscopy GmbH, Jena, Germany)
and ImageJ (National Institutes of Health, Bethesda, MD,
USA) (Collins, 2007).
2.10. High-resolution synchrotron-radiation-based X-ray
phase-contrast microCT (HR microCT)
Lung sections of a third set of OVA-induced asthmatic mice
(n = 2) and a control mouse following the schedule and
conditions as described in Fig. 1 were also studied using a CT
set-up with higher resolution. For this aim the procedure for
sample preparation was the following: the trachea was
cannulated, then filled and fixed with 4% paraformaldehyde
(PFA), and subsequently single lobes of the lung were
embedded in a 5% agarose-gel. Finally, 500 mm-thick slices
were cut using a Vibratome (Leica VT 1000S; Leica, Swit-
zerland). The slices were placed with a droplet of PBS
between two round pieces of polypropylene foil, secured
within aluminium rings. These were glued together to create a
closed chamber for the slices (Olendrowitz et al., 2012). These
slices were then imaged with a divergent X-ray beam of
17.5 keV at the beamline ID22 Ni at the European Synchro-
tron Radiation Facility (ESRF) in Grenoble. The beam was
focused to less than 100 nm  100 nm by Kirkpatrick–Baez
(KB) mirrors and free propagation phase-contrast images
recorded with a FReLoN camera (Analog and Transient
Electronic ESRF group) coupled to a scintillator (Weitkamp et
al., 1999). The sample was placed at the maximum possible
defocus distance to achieve the highest field of view. Using a
ten-fold objective lens behind the scintillator and the magni-
fication of the KB beam an effective pixel size of 430 nm was
achieved. Tomographic scans with a series of 1500 images over
a full rotation of 360 were recorded for several specimens of
asthma and control mice. Phase retrieval was performed using
the single-distance Holo-tomo reconstruction algorithm
(Cloetens et al., 1999) implemented at the beamline. Before
3D reconstruction, each projection image was corrected by an
image of the empty beam and aligned to the other projections
before phase retrieval was performed.
2.11. Analysis and statistics
The 3D rendering of the data sets was performed with
VGStudio Max 2.2 (Volume Graphics, Heidelberg, Germany).
For mask generation, IDL 7.0 (Research Systems; Boulder,
CO, USA) and ImageJ (National Institutes of Health;
Bethesda, MD, USA) were used (Abra`moff et al., 2004).
Pore3D, a proprietary software library developed by the
SYRMEP group, was applied to analyse the 3D barium
distribution as well as to quantify the air and tissue content of
the lung within volumes of interest (VOIs) (Brun et al., 2010).
Statistical analysis was performed using MINITAB (Minitab
Ltd; Coventry, UK) and utilizing a one-way ANOVA test
with Tukey 90% simultaneous confidence intervals for the
computed parameters (Ryan et al., 2005; Dunn, 1961).
3. Results
3.1. XPCT in combination with single-distance phase retrieval
is a valuable tool for lung imaging
In order to evaluate the usefulness of phase retrieval in our
experiment, we performed two scans of a mouse lung sample
in XPCT at sample-to-detector distances of 7 and 30 cm. At
the distance of 7 cm only minor edge effects were present and
therefore this essentially resembles the absorption-based
setup in classical CT, despite the fact that the scan was
performed with a monochromatic X-ray source. In contrast,
scanning the same sample at a sample-to-detector distance of
30 cm provides sufficient phase contrast. Phase retrieval was
applied to the projection images of the second scan before
3D reconstruction with FBP was performed. This procedure
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matches the same scheme used in this study. As a basis for a
quantitative comparison, we calculated the contrast-to-noise
ratio (CNR) using the following equation:




 1=2 ; ð1Þ
where g1 and g2 denote the mean grey value of two adjoining
tissues and 21 and 
2
2 reflect their noise level, measured as
squared standard deviation in a region of interest (ROI)
(Mohammadi et al., 2014). In each sample and on five recon-
structed slices homogeneously distributed over the whole
lung, eight circular two-dimensional ROIs (size 0.4 mm2)
solely containing either air or lung soft-tissue were defined
and analysed. We determined a CNR between air and lung-
tissue of about 20.0 in the phase-retrieved data set at 30 cm
and 1.9 at 7 cm without PhR. In addition, only minor blurring
of the phase-retrieved images was found (data not shown).
These results demonstrate that the combination of XPCTwith
single-distance phase retrieval is able to increase the soft-
tissue contrast in our samples and setup by a factor of 9.8 when
compared with absorption-based monochromatic X-ray
imaging. This directly translates into an increased sensitivity
that is beneficial for the combined functional and structural
CT imaging approach to visualize mouse lung tissue.
3.2. Macrophages as specific contrast agent for functional CT
The barium sulfate uptake efficacy of M was assessed with
a bench-top microCT. Imaging of a vial, containing 1  105
M loaded with barium sulfate particles and resuspended in
100 ml PBS, showed a 10% increase of the X-ray absorption
when compared with a vial containing 1  105 unlabelled M
as control (data not shown). The WST-1 assay revealed no
influences of the phagocytized barium sulfate particles on the
metabolic activity of the M (data not shown). Furthermore,
no evidence of morphologic alterations was observed in
barium-sulfate-loaded M by light microscopy (data not
shown). In conclusion, the approach to load M with barium
provides sufficient contrast for CT imaging and shows no signs
of acute cell toxicity.
3.3. In vivo optical imaging demonstrates successful intra-
tracheal instillation of MU
In vivo NIRF imaging was performed in order to confirm
the successful i.t. instillation of the M. For this purpose the
M were additionally stained with the NIR cell membrane
label DiD. Fig. 2 shows the in vivo optical imaging results for
the same asthmatic mouse analysed later by fXPCT. A strong
increase in fluorescence intensity was observed over the lung
area directly and 24 h after i.t. instillation of DiD- and barium-
labelled M when compared with the pre-scan. These results
verify the presence of the labelled M in the lung area of the
mouse 24 h after i.t. administration.
3.4. Processing and quantification of fXPCT data sets
All lungs were kept in situ and scanned at the SYRMEP
beamline using a setup that allows for fXPCT. In order to
cover the main central area of the lung, two slightly over-
lapping scans per sample were performed. The original
projection data sets were then processed by the single-distance
in-line phase-retrieval algorithm (Chen et al., 2010) to create
projections predominately showing the  part of the complex
refractive index. These data sets were later on reconstructed
with FBP. In order to analyse the data quantitatively, the
following steps were performed: stitching of the two over-
lapping scans and reorientation of the data sets to allow for
comparison between different samples; masking of the lung to
restrict the analysis to the lung area; segmentation of the three
different components (air, lung soft-tissue and barium); 3D
quantification of structural alterations and depiction of the
barium concentration and distribution.
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Figure 2
In vivo optical imaging results. Fluorescence intensity maps of the same asthmatic mouse used for fXPCT (Fig. 3) before (pre), directly after (T0) and
24 h after (T24) i.t. instillation of 6  106 barium-sulfate-filled and DiD-labelled M are shown. After 24 h, strong fluorescence signals expressed in
normalized counts (NC) are visible over the lung area.
3.4.1. Post-processing steps and descriptive comparison of
the obtained fXPCT lung data sets. The automatic quantifi-
cation of anatomical alterations is based on the splitting of the
data sets into rectangular VOIs. Thus, to ensure that all data
sets are present in the same orientation, the reconstructed
data of the two scanning steps were registered, combined and
re-orientated. In consideration of the memory limitations
in the post-processing algorithms, data sets were re-sampled
down to an isotropic resolution of 14.4 mm. A volume-
rendering representation of the final data sets is shown in
Fig. 3(a) and VOIs in Figs. 3(b) and 3(c). To visualize the
various tissues as well as the i.t. instilled barium-sulfate-loaded
M, pseudo-colours were assigned to different greyscale
ranges. As a result, lung soft-tissue is displayed in red, bones in
grey and highly dense areas related to the barium-containing
M appear yellow. In order to maintain the 3D visibility of the
inner lung structure the air was set to transparent. Given that
barium causes a greater phase shift than lung soft-tissue and
the healthy blank (Blk) contains no barium, the upper limit of
the grey value range representing the lung soft-tissue in Blk
was chosen as a valuable threshold to detect the barium-
loaded M.
The segmented images clearly show an increased soft-tissue
content in sample AA in comparison with the healthy controls
[Figs. 3(a) and 3(b)]. Additionally, the VOI of AA (Fig. 3b)
displays a reduced porosity, which illustrates the airway
obstruction characteristic for asthma. The same effect of
increased soft-tissue content and airway obstruction can to a
certain extent also be seen in the planar slices in Figs. 4(a) and
4(b) (white arrow heads). Furthermore, Fig. 3 demonstrates
that the barium-sulfate-loaded M seem to be distributed in
cluster-like structures throughout the asthmatic lung, which is
also demonstrated in planar reconstructed slices in Figs. 4(c)
and 4(d). High-contrast regions related to barium-sulfate-
loaded M are also present in the lungs of the two healthy
controls CN1 and CN2; however, at a much lower quantity
(yellow spots, Fig. 3b). Note that M derived signals within
the lung in AA appear to be surrounded by lung soft-tissue
and therefore seem to be originating from areas around the
bronchial walls and not from the lumen of the airways
(Fig. 3b). The same location of M was also found in two-
dimensional slices as shown in Fig. 4(c). In the same slices
areas can be found that are solely composed of soft tissue that
is characterized by a lower contrast than the marked spots
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Figure 3
Volume rendering of the fXPCT results and visualization of the M localization. Volume renderings of four 3D reconstructions of phase-retrieved
fXPCT data sets are shown. Each column represents one lung sample of an asthmatic mouse (AA), a healthy mouse without instilled M as negative
control (Blk), and two healthy controls (CN1, CN2). Bone is displayed in grey, soft-tissue in red and barium in yellow (air is not depicted). (a) Illustration
of the entire field of view: more barium and an increased soft-tissue density is shown in AA. (b) VOIs (their origin is indicated by white squares in row 1).
(c) The same VOIs are shown but with higher transparency to allow visualization of the sites where barium-filled M cluster in more detail. Note that in
the VOIs of the AA lung a higher barium content is visible compared with the results obtained in lungs of the negative control Blk and the healthy
controls CN1 and CN2. Additionally, the VOIs of the AA sample show a higher soft-tissue content in comparison with the VOIs of all controls, reflecting
a reduced pulmonary volume and increased soft-tissue content in the asthmatic lung tissue.
assigned to barium. Therefore, it can be excluded that the
detected spots are caused by partial-volume effects. Due to the
fact that no other strong absorbing material is present in the
lung, these high-dense spots most likely represent the instilled
barium-labelled M. Therefore, the detected localization of
the M within the bronchial walls may indicate an active
migration of the instilled M from the airspace into the tissue.
3.4.2. Development of an image-processing scheme for
automatic 3D quantification of morphological alterations.
Since lung tissue has a tree-like structure of airways with
different capillarity, the depiction of the VOIs are of crucial
importance for a VOI-based analysis scheme. On the other
hand, the instilled barium-labelled M produce a weak signal
and might have an inhomogeneous distribution in such a way
that they could be easily missed in an approach focused on the
entire lung. In order to perform a quantitative comparison,
entire lungs were therefore subdivided into three sets of
2 mm-thick bands in the horizontal, vertical and frontal
direction. In the so-generated 32 VOIs per sample, two types
of parameters were analysed: (i) volume ratio (Vol. Ratio),
which defines the volume fraction of a tissue or material of
interest compared with the total volume of a VOI, and (ii)
structural thickness (St. Th.) of either the airways or the
surrounding tissue. Structural thickness is calculated by
analysing the maximal size of spheres which can be inscribed
in the structure as proposed by Hildebrand & Ruegsegger
(1997) and implemented in the software Pore3D (Brun et al.,
2010). These two parameters are directly related to airway
wall thickening and airway obstruction and therefore reflect
structural changes characteristic for asthmatic lung tissue.
3.4.3. Quantification of morphological changes in the lung.
In addition to visual inspection of the rendered fXPCT data
sets, quantification of structural changes was a further aim of
the study. For this purpose the average and standard variation
of the parameters Vol. Ratio and St. Th. were calculated in
each sample and in each of the horizontal, vertical and trans-
vertical sets of VOIs, respectively
(Table 1). We found an approximately
17% reduced air content as well as a
61% increase in the soft-tissue
Vol. Ratio in the AA sample compared
with all controls (Table 1). In addition,
airway obstruction as a hallmark of
asthma is clearly reflected in the results
of the St. Th. measurements showing
a 32% St. Th. reduction of the mean
airway thickness in AA compared with
all healthy animals and, vice versa, a
48% higher St. Th. in the lung soft-
tissue (Table 1).
In order to prove whether the results
obtained in the individual VOIs of each
data set are significantly different in
between the samples, we used a one-
way ANOVA test with Tukey 90%
simultaneous confidence intervals to
test the difference of the mean values of
the analysed parameters (Vol. Ratio of
air and soft-tissue and St. Th. of airways
and tissue) (Ryan et al., 2005). The
comparison of AA and Blk revealed
reliable differences for all analysed
parameters. Even the minor differences
of these parameters between Blk, CN1
and CN2 were found to be statistically
significant, demonstrating the sensitivity
of our fXPCT approach. Therefore,
based on the chosen parameters (air
and soft-tissue volume ratio and mean
airway and soft-tissue thickness), the
asthmatic and the three control lung
samples can be successfully distin-
guished, indicating that this parameter
set can be used to preclinically monitor
structural changes in asthmatic lungs.
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Figure 4
Manifestation of the structural alterations in asthmatic lung tissue and localization of the barium-
sulfate-labelled macrophages. Detailed views of single slices of the PhR reconstruction are shown in
(a) and (c) for the asthmatic sample (AA) and in (b) and (d) for one control (CN1). Indicated by
white arrow heads in (a) and contrary to the same locations marked in (b), thickening of the
bronchial walls as well as increased soft-tissue content in the smaller airways can be seen in the
asthmatic lung sample. In (c) and (d) areas within the grey value range assigned to barium are
marked in red, indicating the location of the instilled macrophages. Note that the barium-containing
macrophages can be localized within the soft tissue, showing the ‘red dots’ completely surrounded
by tissue.
In addition, the histogram of the  distribution within the
samples, which was normalized to the total amount of analysed
voxels for each mouse, showed a more dominant interval in
AA (grey values 45–55, data not shown). This result suggests
that during the course of asthma not only structural but also
changes in the composition of the lung tissue occur, which may
be the result of the presence of oedema, an increased mucus
production or alterations in the collagen fibres within the lung.
3.4.4. Quantitative analysis of the barium concentration
within the lungs. As shown in Fig. 3 (in yellow), barium-filled
M can be detected in AA and to a lower extent in CN1 and
CN2. Following the same scheme used to quantify the soft-
tissue content, but applied to the barium segment of the data
set, we found a Vol. Ratio of about 0.1% for barium in the AA
lung (Table 1). The barium concentration in the two healthy
controls CN1 and CN2 was below 1% and therefore appear
as 0 in Table 1: The Blk mouse that did not receive barium-
filled M (Blk) was used to set up the threshold and conse-
quently shows no barium content within the whole lung. The
Tukey intervals for barium content (data not shown) are all
positive and therefore confirm that the Vol. Ratio of the
barium content is significantly larger in the AA lung sample
than in the Blk and CN mice.
In summary, bronchial wall thickening and airway
obstruction in asthmatic mouse lung tissue can be visualized in
fXPCT data sets [Figs. 3, 4(a) and 4(b)]. Instilled M appear
within clusters around the bronchial walls [Figs. 3, 4(c) and
4(d)]. With our approach we can also quantify these altera-
tions using automatically generated 3D morphologic para-
meters. These parameters, i.e. Vol. Ratio of air, barium and
lung soft-tissue and St. Th. of air and lung soft-tissue, showed
significant differences between AA and healthy controls in
accordance with the known pathological features in lungs of
an asthma mouse model.
3.5. Fluorescence microscopy and HR microCT confirm the
accumulation of MU in asthmatic lung tissue
In order to confirm the accumulation and to further analyse
the location of the instilled barium-filled and DiD-labelled
M within the lung observed by fXPCT, we performed
fluorescence microscopy and HR microCT on lung sections.
Since the preparation process and the analysis at the
SYRMEP beamline resulted in the deterioration of the
samples and excluded histological analysis, fluorescence
microscopy and HR microCT were performed with lungs of
a different cohort of mice, but strictly following the same
protocol for asthma induction and instillation of M (Fig. 1),
including the use of the same batch of OVA.
Representative results of the fluorescence microscopy
performed on cryosections of a lung of an asthmatic mouse
(AA) and a control lung (CN) are shown in Figs. 5(a) and 5(b).
Instilled barium- and DiD-labelled M are shown in red,
DAPI stained nuclei appear blue and an anti-CD68 antibody
(Ab) which binds to both the applied and endogenous M is
shown in green. As a result, the instilled barium- and DiD-
labelled M appear yellow in the merged image. We observed
DiD-labelled M in the small alveoli [Figs. 5(a) and 5(b),
white arrows] in both the CN and the AA lung samples. As
already seen in the fXPCT analysis, more instilled M are
present in the AA lung. Moreover, only in the asthmatic tissue
were we able to detect an accumulation of instilled M within
lung areas of high cellular density [Fig. 5(a), detailed view].
These clusters of cells were found throughout the lung and in
close proximity to the bronchi. Additionally, a higher number
of endogenous M (green) was found in the asthmatic lung
[Fig. 5(a), green staining].
HR microCT examination clearly verified the presence of
the barium-filled M inside the lung (dark spots), as shown in
Figs. 5(c) and 5(d), for two lung sections from an asthmatic and
a control mouse, respectively. In both asthmatic and healthy
lungs, barium-filled M were detected throughout the lung
tissues. However, in contrast to the healthy sample, the asth-
matic sample additionally displayed areas around the bronchi
with an increased accumulation of M (white rectangle).
Furthermore, thickening of the bronchial walls was observed
in the asthmatic tissue [Fig. 5(c), white arrow head] compared
with the healthy control [Fig. 5(d)], reflecting the presence of
the disease.
Figs. 5(e) and 5(f) show PAS-stained histological slices from
lungs of an OVA-induced asthma mouse (AA) and a healthy
control (CN). Red dots indicate that mucus production is
solely present in the asthmatic lung (Fig. 5e). Furthermore,
airway wall thickening can be observed (black arrow head)
in the AA slide only. These findings represent typical char-
acteristics of asthma and confirm the presence of an acute
asthma reaction in these mice. In addition, ELISA analysis of
the sera revealed increased IgG1 titre for all asthma mice
(data not shown), verifying a successful immunization.
4. Discussion
This study presents a novel functional in-line free propagation
X-ray phase-contrast CT imaging approach (fXPCT) that
enables the depiction of both structural features of lung tissue
and the accumulation of barium-labelled M in the lungs of
mice after intratracheal instillation. We show that fXPCT can
be applied for CT-based immune cell tracking studies.
Furthermore, this method allows the quantification of struc-
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Table 1
Mean values  standard deviation of the considered parameters.
The pooled standard deviations for the Vol. Ratio (%) parameter were 0.04
for barium, 4.95 for alveoli and 4.94 for tissue. For the St. Th. (mm)
parameter the pooled standard deviation were68 for alveoli and11 for soft
tissue.
Sample Barium Air Soft tissue
Vol. Ratio (%) AA 0.10  0.07 64.62  6.78 35.28  6.75
Blk 0.00  0.00 78.32  3.43 21.68  3.43
CN1 0.00  0.00 74.28  4.75 25.72  4.75
CN2 0.00  0.00 81.85  4.21 18.15  4.21
St. Th. (mm) AA 188  39 83  15
Blk 254  53 54  9
CN1 256  83 60  9
CN2 315  87 53  7
tural changes in whole asthmatic lungs
in situ by measuring parameters like the
volume ratios of air, soft-tissue and the
mean airway and soft-tissue thickness,
thereby assessing hallmarks of asthma
such as bronchial wall thickening and
airway obstruction.
By applying a single-distance phase-
retrieval algorithm (Paganin et al., 2002)
to decouple phase from absorption
information, we raised the CNR of low-
absorbing unstained lung soft-tissue by
a factor of ten when compared with
classical FBP (Mohammadi et al.,
2014; Chen et al., 2010). It has to be
emphasized that this factor is strongly
related to the experimental setup
used, including the sample-to-detector
distance, the type of samples, the pixel
size of the camera system, the quality of
the X-ray beam, the phase-retrieval and
reconstruction algorithms, and does
therefore not represent a general rule
for comparing phase-retrieved with
non-phase-retrieved CT reconstructions
(Donnelly et al., 2003). In a different
setup even a factor of up to 200 was
reported by Beltran et al. (2011).
Another way to improve the detect-
ability of contrast agents would be K-
edge imaging (Cormode et al., 2010), in
spite of the increase in sensitivity in
K-edge imaging in combination with a
non-energy-resolved detector requiring
two scans with at least one using a
photon energy higher than optimal for
soft-tissue contrast.
Single-distance phase retrieval uses,
as the name implies, only one projection
to calculate the -distribution of the
refractive index. Therefore, it simplifies
the experimental setup and minimizes
the acquisition time. This is of particular
advantage for unfixed biological
samples as used in this study, as it
reduces the influence of alterations
that occur within the samples over
time. However, single-distance phase
retrieval is in principle based on the assumption that the
studied sample is a ‘homogeneous’ object, meaning it only
contains one known -to- ratio (Chen et al., 2011; Gureyev et
al., 2009). Since this is not the case for our biological samples, a
-to- ratio optimized for lung tissue was used. Lung is only
composed of low-Z materials (Z < 10) for which Wu et al.
(2005) showed already that single-distance phase-retrieval
algorithms can be applied. Nevertheless, the generated
reconstructions are not valid for the analysis of dense struc-
tures like bony components (Beltran et al., 2011). If the
skeleton is of interest, an additional phase-retrieval step in
combination with a different -to- ratio should be applied
as shown by Beltran et al. (2011). Here we consider a low
concentration of barium-sulfate-loaded M (less than 0.2%)
only a minor disturbance of the assumed ‘homogeneity’
within the lung although barium has a Z value of 56. The
calculated ten-fold increase in CNR is based on the
comparison with a scan that uses the same setup, but with a
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Figure 5
Validation of the fXPCT results by fluorescence microscopy, HR microCT and histology. (a, b)
Fluorescence microscopy of lung sections of (a) an asthmatic (AA) and (b) a control mouse (CN).
Nuclei were stained with DAPI (blue) and M were immuno-stained with an anti-CD68 antibody
(green). DiD-labelled M are shown in red, whereas instilled M appear yellow due to the double
staining with CD68 and DiD. Endogenous M are shown in green and can be seen in alveoli of both
AA and CN lungs, but seem to form clusters in AA (a and b). Instilled DiD-labelled M are also
visible in both AA and CN lung samples (white arrows). In contrast to the CN, the AA sample
shows high cellular density areas (white rectangle and detailed view), where several CD68 positive
cells and clusters of instilled M can be observed. Unlike the AA sample, the CN does not show
these areas, which may explain the increased soft-tissue ratio and the airway obstruction found in the
fXPCTresults. (c, d) Representative cross sections of HR microCT for AA and CN vibratome lung
section. An increased wall thickness (white arrow head) for AA (c) and the location of the labelled
M (black dots) can be clearly depicted. M can be seen in both CN and AA, (c) shows an area
with higher cell density and accumulation of M (white rectangle). (e and f ) PAS-stained lung
sections of an asthmatic (AA) and a control mouse (CN). Increased wall thickness in asthmatic lung
tissue (black arrow head) is depicted. Red dots are exclusively visible in asthmatic lungs and depict
mucus production.
minimized sample-to-detector distance, generating projection
images with predominately absorption-based contrast.
Therefore, the reconstructed absorption-based data set was
acquired with quasi-monochromatic X-rays known to
generate higher-quality data than conventional microCTs
with the same spatial resolution (Sera et al., 2005). Thus, the
gain in contrast with single-distance phase retrieval is even
more prominent when compared with conventional bench-
top microCT scans. This increase in contrast directly leads to
an increased sensitivity, which in our case did not only enable
the depiction but also the quantification of parameters of
structural changes in the entire asthmatic lung in 3D, namely
the volume ratios of air, soft-tissue and the mean airway
thickness, and was the prerequisite for the detection of the
labelled M.
In contrast to other studies that analyse mouse lung struc-
ture at a micrometre scale (Yong et al., 2009; Sera et al., 2005;
Kitchen et al., 2005), we kept the lung in situ by filling the
airways with air at a constant pressure. We believe that in this
way the shape of the lung, which is critically dependent on the
pressure and the boundaries given by the ribcage, can be
compared with an in vivo situation. In previous studies using
the same asthma mouse model and sample preparation
scheme, we found that the overall lung volume (soft-tissue and
air content) was greater in asthmatic than in the healthy mice.
That means that the asthmatic lungs can be more inflated at
the same pressure pointing to a change in the elasticity of the
lung tissue. This finding may be reflected in the altered -value
distribution of the soft-tissue in the asthmatic sample and
supports the understanding that in asthma, in addition to
inflammation, changes in the composition of lung tissue occur,
that lead to a loss in elastic recoil. This loss of elasticity was
already observed in patients (Gelb & Zamel, 2002; Gelb et al.,
2002) and confirmed our previous studies.
With this study we present a novel set of parameters
[volume ratio (Vol. Ratio) and structural thickness (St. Th.)
of airways and soft-tissue] and show their potential use in
describing differences between asthmatic and healthy lung
tissue. By applying fXPCT we determined a 17% reduced air
content, a 32% reduced mean airway thickness and a 61%
increase in the soft-tissue content in the asthmatic lung tissue
compared with controls, demonstrating that in contrast to
histology or conventional CT our approach can precisely
measure structural alterations and illustrate them in 3D. The
inflammatory response in asthma eventually leads to bronchial
obstruction, caused by structural abnormalities such as
hypertrophy of airway smooth muscle, sub-epithelial fibrosis,
goblet cell hyperplasia, and proliferation of airway blood
vessels and nerves. Since routinely most of these morpholo-
gical changes of airway remodelling are visualized histologi-
cally in lung sections in both humans and mouse models (Al
Heialy et al., 2011; Blacquie`re et al., 2010; Leong & Huston,
2001; Epstein, 2004), the quantification of these changes has
been difficult to date. While there are limited approaches by
conventional CT and MRI, these techniques are restricted by
a low resolution. In particular, minor alterations of the lung
tissue in asthma cannot be visualized with the limited spatial
resolution of clinical CT scanners. Therefore, up to now the
diagnosis of asthma in CT is based on lung densitometry
measuring air trapping caused by disturbed ventilation of
the lung (Washko et al., 2012). Our approach provides novel
parameters which may used in both preclinical asthma models
and clinical practice to classify and monitor asthma of
different severity and/or to access the influence of an asthma
therapy on airway remodelling.
In addition to anatomical information, the increased
sensitivity of our fXPCT technique in comparison with
conventional microCT allows for the depiction of the distri-
bution of i.t. instilled barium-sulfate-loaded immortalized
alveolar macrophages as ‘physiological’ contrast agent within
the 3D lung structure. This, to our knowledge, represents the
first approach of using barium-sulfate-loaded macrophages
as contrast agents for CT-based cell tracking studies in an
experimental allergic airways disease model. So far the use of
synchrotron-radiation-based CT for cell tracking has only
been reported in a few applications such as imaging small
clusters of tumour cells ex vivo loaded with gold nanoparticles
(Astolfo et al., 2013). The visualization of pancreatic islet cells
encapsulated in barium microcapsules is another example for
CT-based cell tracking (Arifin et al., 2012). We found a higher
barium content in the asthmatic lung sample, which is most
likely due to a more clustered distribution of the instilled
macrophages in cell-dense areas around the bronchi, a finding
which needs further investigation by high-resolution tomo-
graphy. This result is supported by our validation experiments
with fluorescence microscopy and HR microCT, all techniques
that share a higher spatial resolution than the used fXPCT
approach. In our experiment in asthmatic lung tissue, 24 h
after instillation, M were predominately found in areas with
an increased cell density. While the implications of these
findings for the pathomechanism of asthma and other lung
disease models require further investigation, our results
demonstrate the benefit of our imaging technique for 3D
localization of cells in specific tissue regions. As the M used
in this study are derived from an immortalized cell line
(Mbawuike & Herscowitz, 1989), no conclusions towards a
similar behaviour of endogenous M can be made.
A current drawback of our method for future clinical
application is the lack of clinical CT systems that provide
phase contrast. This limitation may soon be overcome by the
implementation of novel technologies such as liquid-metal jet
anode systems, miniaturized synchrotrons or grating-inter-
ferometer-based phase-contrast imaging utilizing classical
X-ray sources (Pfeiffer et al., 2006; Tompkins et al., 1998; van
Heekeren et al., 2011). All of these techniques perform well
under laboratory conditions but struggle with different tech-
nical problems, which limit their use in the clinic so far. In
particular, the high radiation dose for grating-based phase-
contrast devices hamper their clinical application at the
moment (Raupach & Flohr, 2011). However, our quantifica-
tion scheme for analysis of lung structure alterations can be
directly translated to any other CTor anatomical lung imaging
technique, providing a spatial resolution high enough to
resolve the lung substructure.
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Our approach presents a proof-of-principle study for
fXPCT imaging that specifically visualizes and quantifies
morphological differences and airway remodelling of the
mouse lung and will support the preclinical validation of newly
developed targeted diagnostics and drug delivery strategies
for lung diseases. Furthermore, our novel imaging approach
provides a solid system for cell tracking studies of immune
cells to investigate the role that macrophages might play in the
development and progression of lung diseases such as asthma.
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